AMGN
Amgen Inc.
Stock
$407.27−14.24 (−3.38%)Close Oct 1, 2026
| Research and development (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $7.6B | +19.1% | 11.6% | 6.0% |
| Research and development (TTM) | $7.6B |
|---|---|
| YoY | +19.1% |
| 5-year CAGR | 11.6% |
| 10-year CAGR | 6.0% |
Research and development
| Period | R&D | YoY |
|---|---|---|
| 2025 | $7.3B | +21.9% |
| 2024 | $6.0B | +24.7% |
| 2023 | $4.8B | +7.9% |
| 2022 | $4.4B | −8.0% |
| 2021 | $4.8B | +14.5% |
| 2020 | $4.2B | +2.2% |
| 2019 | $4.1B | +10.1% |
| 2018 | $3.7B | +4.9% |
| 2017 | $3.6B | −7.2% |
| 2016 | $3.8B | −5.7% |
| 2015 | $4.1B | −5.3% |
| 2014 | $4.3B | +5.2% |
| 2013 | $4.1B | +20.8% |
| 2012 | $3.4B | +6.7% |
| 2011 | $3.2B | +9.4% |
| 2010 | $2.9B | +1.0% |
| 2009 | $2.9B | −5.5% |
| 2008 | $3.0B | −7.2% |
| 2007 | $3.3B | — |